Researchers report promising results for nebokitug, a monoclonal antibody tested for primary sclerosing cholangitis. In a Phase 2 trial, the drug proved safe and showed signs of reducing liver ...

Researchers warn that climate, forest-based livelihoods and weak vector control fuel infections, while stigma and treatment ...